152 related articles for article (PubMed ID: 14707724)
21. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
22. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.
Furuya N; Kawa S; Akamatsu T; Furihata K
Gastroenterology; 1997 Aug; 113(2):593-8. PubMed ID: 9247481
[TBL] [Abstract][Full Text] [Related]
25. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
[TBL] [Abstract][Full Text] [Related]
26. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
27. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
[TBL] [Abstract][Full Text] [Related]
28. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma.
Nakamura Y; Onda M; Uchida E
Pancreas; 1999 Mar; 18(2):133-40. PubMed ID: 10090410
[TBL] [Abstract][Full Text] [Related]
29. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
[TBL] [Abstract][Full Text] [Related]
30. [K-ras mutation in pancreatic juice from patients with pancreatic carcinoma].
Gong X; Chen Y; Chen Y; Lu X
Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):673-6. PubMed ID: 11798705
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
32. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
33. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
34. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
[TBL] [Abstract][Full Text] [Related]
35. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.
Pugliese V; Pujic N; Saccomanno S; Gatteschi B; Pera C; Aste H; Ferrara GB; Nicolò G
Gastrointest Endosc; 2001 Nov; 54(5):595-9. PubMed ID: 11677475
[TBL] [Abstract][Full Text] [Related]
37. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.
Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N
Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868
[TBL] [Abstract][Full Text] [Related]
38. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
39. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
[TBL] [Abstract][Full Text] [Related]
40. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]